Replies to post #199775 on Cytodyn Inc (CYDY)

[Epistemologist]

The BLA has never mattered because the trial only had 47 patients. It was never going to lead to an approval. Using monotherapy to bolster the trial is a NP fantasy. The FDA doesn't work that way. There will have to be another trial which means years until a possible HIV approval.

[3X Charm]

Obviously their is a failure to connect the SP with reality in Cydy land.

Anyway, the narrative is not driving the price down or the trials to fail…that is on MANAGMENT INCOMPETENCE.

THE SP reflects the total lack of belief in Cydy under Nader and his nefarious cable inside and and outside the company. The old shell game no longer works.

“The negative narrative is too transparent. It is becoming less effective by the day.”

[kgromax]

The only thing that matters are facts.

And they are bad:
- Insiders dumping more than 85% on their stocks while they were promising great news "soon"
- Stock price crashing over the last 18 months
- "Sure thing" promises by insiders never met - always a negative surprise
- "Sure thing" expectations by long investors never met - always a negative surprise
- All published study statistics failing to meet statistical standards (e.g., data dredging by looking at sub-pops that were NOT planned before in the statistical plan, WITHOUT the statistical corrections that are mandatory in these cases)
- Investigation by SEC and DOJ focused on the company and its insiders (NOT external investors)
- FDA taking the exceptional step to warn investors that Leronlimab has NOT been proven to work
- Judge publicly criticizing CEO's "unmitigated greed" and threatening
- CEO losing all past lawsuits against shareholders or employees
- Massive turnover of CxOs below the CEO
- CEO asking to his CRO to send an incomplete (=illegal) BLA to the FDA
- Company paying 11 STOCK PROMOTERS to pump its stock, a worldwide record for a 20 employees company
- Some of these promoters ACTING ILLEGALLY on various high traffic websites

REALITY IS SAD